In Situ Synthesis of an Anticancer Peptide Amphiphile Using Tyrosine Kinase Overexpressed in Cancer Cells

(1) Gaucher, G.; Dufresne, M. H.; Sant, V. P.; Kang, N.; Maysinger, D.; Leroux, J. C. Block copolymer micelles: preparation, characterization and application in drug delivery. J. Controlled Release 2005, 109, 169−188.

(2) Nishiyama, N.; Kataoka, K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol. Ther. 2006, 112, 630−648.

(3) Blanazs, A.; Armes, S. P.; Ryan, A. J. Self-Assembled Block Copolymer Aggregates: From Micelles to Vesicles and their Biological Applications. Macromol. Rapid Commun. 2009, 30, 267−277.

(4) Cui, H. G.; Webber, M. J.; Stupp, S. I. Self-Assembly of Peptide Amphiphiles: From Molecules to Nanostructures to Biomaterials. Biopolymers 2010, 94, 1−18.

(5) Della Rocca, J.; Liu, D. M.; Lin, W. B. Nanoscale Metal-Organic Frameworks for Biomedical Imaging and Drug Delivery. Acc. Chem. Res. 2011, 44, 957−968.

(6) Yang, Z. M.; Xu, K. M.; Guo, Z. F.; Guo, Z. H.; Xu, B. Intracellular Enzymatic Formation of Nanofibers Results in Hydrogelation and Regulated Cell Death. Adv. Mater. 2007, 19, 3152−3156.

(7) Tanaka, A.; Fukuoka, Y.; Morimoto, Y.; Honjo, T.; Koda, D.; Goto, M.; Maruyama, T. Cancer Cell Death Induced by the Intracellular Self-Assembly of an Enzyme-Responsive Supramolecular Gelator. J. Am. Chem. Soc. 2015, 137, 770−775.

(8) Pires, R. A.; Abul-Haija, Y. M.; Costa, D. S.; Novoa-Carballal, R.; Reis, R. L.; Ulijn, R. V.; Pashkuleva, I. Controlling Cancer Cell Fate Using Localized Biocatalytic Self-Assembly of an Aromatic Carbohydrate Amphiphile. J. Am. Chem. Soc. 2015, 137, 576−579.

(9) Zhan, J.; Cai, Y. B.; He, S. S.; Wang, L.; Yang, Z. M. Tandem Molecular Self-Assembly in Liver Cancer Cells. Angew. Chem., Int. Ed. 2018, 57, 1813−1816.

(10) He, H. J.; Xu, B. Instructed-Assembly (iA): A Molecular Process for Controlling Cell Fate. Bull. Chem. Soc. Jpn. 2018, 91, 900− 906.

(11) Yamamoto, S.; Nishimura, K.; Morita, K.; Kanemitsu, S.; Nishida, Y.; Morimoto, T.; Aoi, T.; Tamura, A.; Maruyama, T. Microenvironment pH-Induced Selective Cell Death for Potential Cancer Therapy Using Nanofibrous Self-Assembly of a Peptide Amphiphile. Biomacromolecules 2021, 22, 2524−2531.

(12) Sherr, C. J. The Pezcoller Lecture: Cancer cell cycles revisited. Cancer Res. 2000, 60, 3689−3695.

(13) Mendelsohn, J.; Baselga, J. The EGF receptor family as targets for cancer therapy. Oncogene 2000, 19, 6550−6565.

(14) Mendelsohn, J.; Baselga, J. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J. Clin. Oncol. 2003, 21, 2787−2799.

(15) Roberts, P. J.; Der, C. J. Targeting the Raf-MEK-ERK mitogenactivated protein kinase cascade for the treatment of cancer. Oncogene 2007, 26, 3291−3310.

(16) Dancey, J. E.; Chen, H. X. Strategies for optimizing combinations of molecularly targeted anticancer agents. Nat. Rev. Drug Discovery 2006, 5, 649−659.

(17) Hoelder, S.; Clarke, P. A.; Workman, P. Discovery of small molecule cancer drugs: Successes, challenges and opportunities. Mol. Oncol. 2012, 6, 155−176.

(18) Holohan, C.; Van Schaeybroeck, S.; Longley, D. B.; Johnston, P. G. Cancer drug resistance: an evolving paradigm. Nat. Rev. Cancer 2013, 13, 714−726.

(19) Roskoski, R. The ErbB/HER family of protein-tyrosine kinases and cancer. Pharmacol. Res. 2014, 79, 34−74.

(20) Janne, P. A.; Yang, J. C. H.; Kim, D. W.; Planchard, D.; Ohe, Y.; Ramalingam, S. S.; Ahn, M. J.; Kim, S. W.; Su, W. C.; Horn, L.; Haggstrom, D.; Felip, E.; Kim, J. H.; Frewer, P.; Cantarini, M.; Brown, K. H.; Dickinson, P. A.; Ghiorghiu, S.; Ranson, M. AZD9291 in EGFR Inhibitor-Resistant Non-Small-Cell Lung Cancer. N. Engl. J. Med. 2015, 372, 1689−1699.

(21) Batenjany, M.; Bartnicki, D.; Ambuel, Y.; Wiepz, G.; Bertics, P.; Hayes, S. Rapid, ELISA-based measurement of protein tyrosine kinase activity using the K-LISATM Kit. Nat. Methods 2005, 2, iv−v.

(22) Ullrich, A.; Coussens, L.; Hayflick, J. S.; Dull, T. J.; Gray, A.; Tam, A. W.; Lee, J.; Yarden, Y.; Libermann, T. A.; Schlessinger, J.; Downward, J.; Mayes, E. L. V.; Whittle, N.; Waterfield, M. D.; Seeburg, P. H. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 1984, 309, 418−425.

(23) Roy, S.; Dasgupta, A.; Das, P. K. Alkyl chain length dependent hydrogelation of L-tryptophan-based amphiphile. Langmuir 2007, 23, 11769−11776.

(24) Feng, Z. Q. Q.; Wang, H. M.; Chen, X. Y.; Xu, B. SelfAssembling Ability Determines the Activity of Enzyme-Instructed Self-Assembly for Inhibiting Cancer Cells. J. Am. Chem. Soc. 2017, 139, 15377−15384.

(25) Stamos, J.; Sliwkowski, M. X.; Eigenbrot, C. Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J. Biol. Chem. 2002, 277, 46265−46272.

(26) Sridhar, S. S.; Seymour, L.; Shepherd, F. A. Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancer. Lancet Oncol. 2003, 4, 397−406.

(27) Dungo, R. T.; Keating, G. M. Afatinib: First Global Approval. Drugs 2013, 73, 1503−1515.

(28) Gao, Y.; Shi, J.; Yuan, D.; Xu, B. Imaging enzyme-triggered selfassembly of small molecules inside live cells. Nat. Commun. 2012, 3, 1033.

(29) Ishida, M.; Watanabe, H.; Takigawa, K.; Kurishita, Y.; Oki, C.; Nakamura, A.; Hamachi, I.; Tsukiji, S. Synthetic Self-Localizing Ligands That Control the Spatial Location of Proteins in Living Cells. J. Am. Chem. Soc. 2013, 135, 12684−12689.

(30) Golovina, V. A.; Blaustein, M. P. Spatially and functionally distinct Ca2+ stores in sarcoplasmic and endoplasmic reticulum. Science 1997, 275, 1643−1648.

(31) Michalak, M.; Corbett, E. F.; Mesaeli, N.; Nakamura, K.; Opas, M. Calreticulin: one protein, one gene, many functions. Biochem. J. 1999, 344, 281−292.

(32) Walter, P.; Ron, D. The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation. Science 2011, 334, 1081− 1086.

(33) Tabas, I.; Ron, D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat. Cell Biol. 2011, 13, 184−190.

(34) Hotamisligil, G. S. Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease. Cell 2010, 140, 900−917.

(35) Harding, H. P.; Zhang, Y. H.; Zeng, H. Q.; Novoa, I.; Lu, P. D.; Calfon, M.; Sadri, N.; Yun, C.; Popko, B.; Paules, R.; Stojdl, D. F.; Bell, J. C.; Hettmann, T.; Leiden, J. M.; Ron, D. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell 2003, 11, 619−633.

(36) Feng, Z. Q. Q.; Wang, H. M.; Wang, S. Y.; Zhang, Q.; Zhang, X. X.; Rodal, A. A.; Xu, B. Enzymatic Assemblies Disrupt the Membrane and Target Endoplasmic Reticulum for Selective Cancer Cell Death. J. Am. Chem. Soc. 2018, 140, 9566−9573.

(37) Clavadetscher, J.; Hoffmann, S.; Lilienkampf, A.; Mackay, L.; Yusop, R. M.; Rider, S. A.; Mullins, J. J.; Bradley, M. Copper Catalysis in Living Systems and In Situ Drug Synthesis. Angew. Chem., Int. Ed. 2016, 55, 15662−15666.

(38) Clavadetscher, J.; Indrigo, E.; Chankeshwara, S. V.; Lilienkampf, A.; Bradley, M. In-Cell Dual Drug Synthesis by Cancer-Targeting Palladium Catalysts. Angew. Chem., Int. Ed. 2017, 56, 6864−6868.

(39) Eda, S.; Nasibullin, I.; Vong, K.; Kudo, N.; Yoshida, M.; Kurbangalieva, A.; Tanaka, K. Biocompatibility and therapeutic potential of glycosylated albumin artificial metalloenzymes. Nat. Catal. 2019, 2, 780−792.